Charles O’Shaughnessy

12.8k citations

43 papers · 9.4k indexed · 5 hit papers · h-index 27

Impact in

Cardiology and Cardiovascular Medicine top 0.2%
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Valve Diseases and Treatments
- Acute Myocardial Infarction Research
Surgery top 0.1%
- Coronary Interventions and Diagnostics
- Peripheral Artery Disease Management

Papers in

Cardiology and Cardiovascular Medicine 23
- Cardiac Valve Diseases and Treatments 12
- Antiplatelet Therapy and Cardiovascular Diseases 10
Radiology, Nuclear Medicine and Imaging 23
- Cardiac Imaging and Diagnostics 23

Co-authors: Jeffrey J. Popma Ronald Caputo Martin B. Leon Gregg W. Stone Peter J. Fitzgerald Stephen G. Ellis Richard E. Kuntz J. Tift Mann
Journals: Journal of the American College of Cardiology (12 papers)The American Journal of Cardiology (6 papers)JACC: Cardiovascular Interventions (6 papers)Catheterization and Cardiovascular Interventions (4 papers)New England Journal of Medicine (3 papers)
Partner nations: United States New Zealand Australia

In The Last Decade

Charles O’Shaughnessy

42 papers receiving 9.1k citations

Hit Papers

5 papers align trajectories log scale

Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease 2005 · 1.0k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2005 New England Journal of Medicine
2005 JAMA
2004 Circulation
2004 New England Journal of Medicine
2003 New England Journal of Medicine

Peers

Countries citing papers authored by Charles O’Shaughnessy

Since Specialization

Citations

This map shows the geographic impact of Charles O’Shaughnessy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles O’Shaughnessy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles O’Shaughnessy more than expected).

Fields of papers citing papers by Charles O’Shaughnessy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles O’Shaughnessy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles O’Shaughnessy. The network helps show where Charles O’Shaughnessy may publish in the future.

Co-authors

The 25 scholars most cited alongside Charles O’Shaughnessy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles O’Shaughnessy Line = papers co-authored together Charles O’Shaughnessy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	5-Year Follow-Up of Polytetrafluoroethylene-Covered Stents Compared With Bare-Metal Stents in Aortocoronary Saphenous Vein Grafts JACC: Cardiovascular Interventions ·Gregg W. Stone, Sheldon Goldberg, Charles O’Shaughnessy, Mark Midei, Robert Siegel, Ecaterina Cristea, George Dangas, Alexandra J. Lansky, Roxana Mehran	2011	39
2	A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: Final results of the ZoMaxx II trial International Journal of Cardiology ·William A. Gray, Alan C. Yeung, Donald E. Cutlip, Jeffrey J. Popma, Peter J. Fitzgerald, David O. Williams, (unknown), Charles O’Shaughnessy, Paul Overlie, J. Tift Mann, Louis Cannon, James Hermiller, Timothy D. Henry, Robert Whitbourn, Thomas Stuckey, Mark Midei, Jessie Coe, Lewis B. Schwartz	2011	5
3	Safety and Efficacy of Renal Artery Stenting Following Suboptimal Renal Angioplasty for De Novo and Restenotic Ostial Lesions: Results from a Nonrandomized, Prospective Multicenter Registry Journal of Vascular and Interventional Radiology ·John R. Laird, John H. Rundback, R. Eugene Zierler, Gary J. Becker, Charles O’Shaughnessy, John Shuck, David E. Allie, Jeffrey W. Olin, Kim Cantwell-Gab, Jack Thomas	2010	18
4	Long-Term Safety and Efficacy With Paclitaxel-Eluting Stents JACC: Cardiovascular Interventions ·Stephen G. Ellis, Gregg W. Stone, David A. Cox, James Hermiller, Charles O’Shaughnessy, Tift Mann, Mark Turco, Ronald Caputo, Patrick Bergin, Thomas S. Bowman, Donald S. Baim	2009	101
5	Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial European Heart Journal ·Stephen G. Ellis, Charles O’Shaughnessy, Sandra L. Martin, K.M. Kent, Trudy McGarry, Mark Turco, Dean J. Kereiakes, Jeffery J. Popma, Mark I. Friedman, Joerg Koglin, Gregg W. Stone, (unknown)	2008	41
6	Reduced Risk of Restenosis in Small Vessels and Reduced Risk of Myocardial Infarction in Long Lesions With the New Thin-Strut TAXUS Liberté Stent JACC: Cardiovascular Interventions ·Mark Turco, John A. Ormiston, Jeffrey J. Popma, Jack Hall, Tift Mann, Louis Cannon, Mark Webster, Gregory Mishkel, Charles O’Shaughnessy, Thomas McGarry, Lazar Mandinov, Keith D. Dawkins, Donald S. Baim	2008	67
7	The StarClose® vascular closure system: Interventional results from the CLIP study Catheterization and Cardiovascular Interventions ·James Hermiller, Charles A. Simonton, Tomoaki Hinohara, D. Lee, Louis Cannon, M. Mooney, Charles O’Shaughnessy, Harold Carlson, Richard Fortuna, Michael Zapien, David Fletcher, Karen DiDonato, T.M. Chou	2006	75
8	Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease Journal of the American College of Cardiology ·David E. Kandzari, Martin B. Leon, Jeffrey J. Popma, Peter J. Fitzgerald, Charles O’Shaughnessy, Michael Ball, Mark Turco, Robert J. Applegate, Paul A. Gurbel, Mark Midei, Sejal Badre, Laura Mauri, Kweli P. Thompson, LeRoy LeNarz, Richard E. Kuntz	2006	250
9	Comparison of the Efficacy of Direct Coronary Stenting With Sirolimus-Eluting Stents Versus Stenting With Predilation by Intravascular Ultrasound Imaging (from the DIRECT Trial) The American Journal of Cardiology ·Atsushi Hirohata, Yoshihiro Morino, Junya Ako, Ryota Sakurai, Maurice Buchbinder, Ronald Caputo, Steven P. Karas, Gregory Mishkel, M. Mooney, Charles O’Shaughnessy, Albert E. Raizner, Robert L. Wilensky, David O. Williams, Shing–Chiu Wong, Paul G. Yock, Yasuhiro Honda, Jeffrey W. Moses, Peter J. Fitzgerald	2006	14
10	Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation Journal of the American College of Cardiology ·Stephen G. Ellis, Jeffrey J. Popma, John M. Lasala, Joerg Koglin, David A. Cox, James Hermiller, Charles O’Shaughnessy, J. Tift Mann, Mark Turco, Ronald Caputo, Patrick Bergin, Joel Greenberg, Gregg W. Stone	2005	122
11	Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease New England Journal of Medicine ·Steven E. Nissen, E. Murat Tuzcu, Paul Schoenhagen, Tim Crowe, William J. Sasiela, John Tsai, John Orazem, Raymond D. Magorien, Charles O’Shaughnessy, Peter Ganz Hit paper breakdown →	2005	1005
12	Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation Journal of the American College of Cardiology ·Neil J. Weissman, Joerg Koglin, David A. Cox, James Hermiller, Charles O’Shaughnessy, J. Tift Mann, Mark Turco, Ronald Caputo, Patrick Bergin, Joel Greenberg, Michael A. Kutcher, S. Chiu Wong, Warren Strickland, M. Mooney, Mary E. Russell, Stephen G. Ellis, Gregg W. Stone	2005	72
13	A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease New England Journal of Medicine ·Gregg W. Stone, Stephen G. Ellis, David A. Cox, James Hermiller, Charles O’Shaughnessy, J. Tift Mann, Mark Turco, Ronald Caputo, Patrick Bergin, Joel Greenberg, Jeffrey J. Popma, Mary E. Russell Hit paper breakdown →	2004	2104
14	The impact of sirolimus-eluting stents in diabetics: Results from the SIRIUS trial Journal of the American College of Cardiology ·Martin B. Leon, David R. Holmes, Charles A. Simonton, Jeffrey W. Moses, Charles O’Shaughnessy, Ronald Caputo, Shing Chiu Wong, Maurice Buchbinder, Greg Chapman, Richard E. Kuntz	2003	5
15	Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery New England Journal of Medicine ·Jeffrey W. Moses, Martin B. Leon, Jeffrey J. Popma, Peter J. Fitzgerald, David R. Holmes, Charles O’Shaughnessy, Ronald Caputo, Dean J. Kereiakes, David O. Williams, Paul S. Teirstein, Judith Jaeger, Richard E. Kuntz Hit paper breakdown →	2003	3218
16	Comparison of PRE-dilatation vs Direct stenting In Coronary Treatment using the Medtronic AVE S670 Coronary Stent System (the PREDICT trial) The American Journal of Cardiology ·Donald S. Baim, Michael Flatley, Ronald Caputo, Charles O’Shaughnessy, Reginald Low, Claude Fanelli, Jeffery J. Popma, Peter J. Fitzgerald, Richard Kuntz	2001	57
17	Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials) The American Journal of Cardiology ·Dean J. Kereiakes, Thomas J. Linnemeier, Donald S. Baim, Richard E. Kuntz, Charles O’Shaughnessy, James Hermiller, Stan Fink, Alexandra Lansky, Naomi Nishimura, Thomas M. Broderick, Jeffrey J. Popma	2000	50
18	Procedural and late outcomes following MULTI-LINK DUET coronary stent deployment The American Journal of Cardiology ·Dean J. Kereiakes, Mark Midei, James Hermiller, Charles O’Shaughnessy, Richard Schlofmitz, Steven Yakubov, Stan Fink, Frank B. Hu, Naomi Nishimura, Marina Sievers, Marye Ellen Valentine, Thomas M. Broderick, Alexandra Lansky, Jeffrey W. Moses	1999	26
19	Late quantitative angiographic results after NIR stent use: results from the NIRVANA randomized trial end registries Journal of the American College of Cardiology ·Alexandra J. Lansky, Jeffrey J. Popma, R. Mehran, Jorge F. Saucedo, Alexandre Abizaid, Charles O’Shaughnessy, James Hermiller, Donald E. Cutlip, Richard E. Kuntz, D S Baim, M.B. Leon	1998	3
20	Elective GR II stenting in small vessels: multicenter results Journal of the American College of Cardiology ·James P. Zidar, Charles O’Shaughnessy, Lesley Dean, Dennis R. Holmes, P.B. Moore, Ebonie Rogers, Edward T.A. Fry, Albert E. Raizner, William D. Voorhees, M.B. Leon	1998	0

About Charles O’Shaughnessy

Charles O’Shaughnessy is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Surgery, Internal Medicine and Pulmonary and Respiratory Medicine, having authored 43 papers that have together received 9.4k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (35 papers), Cardiac Imaging and Diagnostics (23 papers), Cerebrovascular and Carotid Artery Diseases (14 papers), Cardiac Valve Diseases and Treatments (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Peripheral Artery Disease Management (5 papers), Aortic aneurysm repair treatments (5 papers) and Vascular Procedures and Complications (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (5.6k citations), Surgery (8.2k citations), Radiology, Nuclear Medicine and Imaging (2.9k citations), Pulmonary and Respiratory Medicine (2.7k citations) and Internal Medicine (128 citations). Charles O’Shaughnessy has collaborated with scholars based in United States, New Zealand and Australia. Frequent co-authors include Jeffrey J. Popma, Ronald Caputo, Martin B. Leon, Gregg W. Stone, Peter J. Fitzgerald, Stephen G. Ellis, Richard E. Kuntz, J. Tift Mann, Mark Turco and Dean J. Kereiakes. Their work appears in journals such as Journal of the American College of Cardiology, The American Journal of Cardiology, JACC: Cardiovascular Interventions, Catheterization and Cardiovascular Interventions and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact